<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Points</title>
	<atom:link href="http://www.tapanray.in/tag/points/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Holistic Disease Treatment Solution: Critical For Pharma Success</title>
		<link>http://www.tapanray.in/holistic-disease-treatment-solution-critical-for-pharma-success/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=holistic-disease-treatment-solution-critical-for-pharma-success</link>
		<comments>http://www.tapanray.in/holistic-disease-treatment-solution-critical-for-pharma-success/#comments</comments>
		<pubDate>Mon, 29 Oct 2018 00:00:34 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Albert Bourla]]></category>
		<category><![CDATA[Apple]]></category>
		<category><![CDATA[CDO]]></category>
		<category><![CDATA[CEO]]></category>
		<category><![CDATA[Chart]]></category>
		<category><![CDATA[Chief]]></category>
		<category><![CDATA[critical]]></category>
		<category><![CDATA[diagnosis]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[disease]]></category>
		<category><![CDATA[flow]]></category>
		<category><![CDATA[holistic]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Officer]]></category>
		<category><![CDATA[Onduo]]></category>
		<category><![CDATA[paradigm]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Points]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[solution]]></category>
		<category><![CDATA[stakeholders]]></category>
		<category><![CDATA[success]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[therapy]]></category>
		<category><![CDATA[touch]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=9238</guid>
		<description><![CDATA[The speculation over quite some time has ended now. The most important C-suite office of the world’s top pharma company will find a brand-new occupant at the dawn of a brand-new year, on January 01, 2019. Albert Bourla will now be on &#8230; <a href="http://www.tapanray.in/holistic-disease-treatment-solution-critical-for-pharma-success/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/holistic-disease-treatment-solution-critical-for-pharma-success/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Managing Pharma Investors’ Expectations When The Chips Are Down</title>
		<link>http://www.tapanray.in/managing-pharma-investors-expectations-when-the-chips-are-down/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=managing-pharma-investors-expectations-when-the-chips-are-down</link>
		<comments>http://www.tapanray.in/managing-pharma-investors-expectations-when-the-chips-are-down/#comments</comments>
		<pubDate>Sun, 18 Jun 2017 23:34:19 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[accountability.]]></category>
		<category><![CDATA[activist]]></category>
		<category><![CDATA[bans]]></category>
		<category><![CDATA[Business]]></category>
		<category><![CDATA[Chips]]></category>
		<category><![CDATA[Compliance]]></category>
		<category><![CDATA[domestic]]></category>
		<category><![CDATA[down]]></category>
		<category><![CDATA[Ethics]]></category>
		<category><![CDATA[expectations]]></category>
		<category><![CDATA[export]]></category>
		<category><![CDATA[import]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Investors]]></category>
		<category><![CDATA[Managing]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[Points]]></category>
		<category><![CDATA[practices]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Regulatory]]></category>
		<category><![CDATA[shareholders]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[Trump]]></category>
		<category><![CDATA[USFDA]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=8282</guid>
		<description><![CDATA[Triggered by several critical factors, over a relatively short period of time, a downward spiral is visible with most Indian Pharma stocks, with a significant erosion in market capitalization of many large players in the country. A set of important &#8230; <a href="http://www.tapanray.in/managing-pharma-investors-expectations-when-the-chips-are-down/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/managing-pharma-investors-expectations-when-the-chips-are-down/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>85% of the patented new drugs have therapeutic equivalents…they do not increase the cost of treatment for the common man: Points…Counterpoints</title>
		<link>http://www.tapanray.in/85-of-the-patented-new-drugs-have-therapeutic-equivalentsthey-do-not-increase-the-cost-of-treatment-for-the-common-man-pointscounterpoints/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=85-of-the-patented-new-drugs-have-therapeutic-equivalentsthey-do-not-increase-the-cost-of-treatment-for-the-common-man-pointscounterpoints</link>
		<comments>http://www.tapanray.in/85-of-the-patented-new-drugs-have-therapeutic-equivalentsthey-do-not-increase-the-cost-of-treatment-for-the-common-man-pointscounterpoints/#comments</comments>
		<pubDate>Mon, 21 Jun 2010 01:00:31 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[85%]]></category>
		<category><![CDATA[common]]></category>
		<category><![CDATA[Cost]]></category>
		<category><![CDATA[Counterpoints]]></category>
		<category><![CDATA[do]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[equivalent]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[Have]]></category>
		<category><![CDATA[increase]]></category>
		<category><![CDATA[IP]]></category>
		<category><![CDATA[IPR]]></category>
		<category><![CDATA[man]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[Not]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[patented]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Points]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[therapeutic]]></category>
		<category><![CDATA[they]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=412</guid>
		<description><![CDATA[Affordability of patented drugs has become a major controversial and at the same time a very sensitive issue in the healthcare space of India, just as in many other parts of the world. The government, the NGOs and other stakeholders, &#8230; <a href="http://www.tapanray.in/85-of-the-patented-new-drugs-have-therapeutic-equivalentsthey-do-not-increase-the-cost-of-treatment-for-the-common-man-pointscounterpoints/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/85-of-the-patented-new-drugs-have-therapeutic-equivalentsthey-do-not-increase-the-cost-of-treatment-for-the-common-man-pointscounterpoints/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
